MENINGOCOCCAL IMMUNISATION
Clinical trials for MENINGOCOCCAL IMMUNISATION explained in plain language.
Never miss a new study
Get alerted when new MENINGOCOCCAL IMMUNISATION trials appear
Sign up with your email to follow new studies for MENINGOCOCCAL IMMUNISATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test toddler booster shot for deadly meningitis
⭐️ VACCINE ⭐️ CompletedThis study tested a booster vaccine for meningococcal disease in healthy toddlers aged 12 to 23 months. The children had already received their first meningococcal shots as babies. Researchers gave a single booster dose and checked the children's blood before and after to see how…
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE4 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 03, 2026 14:43 UTC
-
New 5-in-1 shot aims to broaden protection against deadly meningitis
⭐️ VACCINE ⭐️ CompletedThis study tested the safety and immune response of a new investigational vaccine designed to protect against five major groups (A, B, C, W, Y) of meningococcal bacteria, which can cause meningitis and bloodstream infections. It involved 1,215 healthy adolescents (10-17 years) an…
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 03, 2026 14:43 UTC
-
New shot aims to protect youngest children from deadly meningitis
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect infants and toddlers from four major strains of meningococcal disease, a serious bacterial infection that can cause meningitis. It involved over 1,500 healthy children in India and South Africa. Researchers compared the new vacc…
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 14:58 UTC
-
New teen vaccine tested against meningitis threat
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect against four types of meningococcal disease (A, C, W, Y) in healthy teenagers. Researchers compared the new vaccine to an already approved one to see if it worked just as well. They also checked if it was safe and effective when…
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 14:57 UTC
-
New meningitis shot for babies tested in major trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect infants and toddlers from four types of serious meningococcal disease (A, C, W, and Y). It compared the new vaccine to an existing one to see if they worked equally well and were similarly safe. The study involved 840 healthy ba…
Matched conditions: MENINGOCOCCAL IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 17, 2026 13:09 UTC